Abstract 5330: Antitumor activity of potent and selective CDK2 inhibitors as monotherapy and in combination with chemotherapy in models of small cell lung cancer
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Nealia House, Liang Yuan, Christophe Lemetre, Maxine Chen, Philip Ramsden, Scott Ribich, Lakshmi Muthuswamy, Kerrie Faia
Institution: Blueprint Medicines (United States)
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631270
